Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.03
+0.15 (1.52%)
At close: Jun 26, 2026, 4:00 PM EDT
10.30
+0.27 (2.69%)
After-hours: Jun 26, 2026, 7:39 PM EDT
Vir Biotechnology Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Vir Biotechnology stock have an average target of 21.13, with a low estimate of 16 and a high estimate of 30. The average target predicts an increase of 110.67% from the current stock price of 10.03.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vir Biotechnology stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 7 | 7 |
| Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $23 → $27 | Buy | Reiterates | $23 → $27 | +169.19% | Jun 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +99.40% | Jun 4, 2026 |
| Barclays | Barclays | Buy Maintains $30 | Buy | Maintains | $30 | +199.10% | Jun 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $16 | Buy | Maintains | $16 | +59.52% | May 29, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 27, 2026 |
Financial Forecast
Revenue This Year
249.42M
from 68.56M
Increased by 263.82%
Revenue Next Year
112.90M
from 249.42M
Decreased by -54.74%
EPS This Year
-1.37
from -3.16
EPS Next Year
-2.32
from -1.37
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 320.9M | 154.7M | |
| Avg | 249.4M | 112.9M | |
| Low | 192.0M | 66.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 368.1% | -38.0% | |
| Avg | 263.8% | -54.7% | |
| Low | 180.1% | -73.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.20 | -1.87 | |
| Avg | -1.37 | -2.32 | |
| Low | -1.74 | -2.99 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.